Implantation of TCD-10023

2 trials

Sponsors

Terumo Europe N.V., Terumo Corporation

Conditions

Ischemic heart disease

Phase 2

CLINICAL EVALUATION OF NEW TERUMO DRUG ELUTING CORONARY STENT SYSTEM IN THE TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE

Active, not recruitingJPRN-UMIN000006575

Terumo Europe N.V.Ischemic heart disease

Start: 2011-10-01Target: 100Updated: 2026-06-29

Phase 3

Clinical Evaluation of New Terumo drug elUting coRonary stent system in the treatment of patients with coronarY artery disease in Small Vessels in Japanese population

Active, not recruitingJPRN-UMIN000012928

Terumo CorporationIschemic heart disease

Start: 2014-03-24Target: 70Updated: 2026-06-29

Related Papers

Five-year clinical outcomes of a 2.25 mm sirolimus-eluting stent in Japanese patients with very small coronary artery disease: final results of the CENTURY JSV study

Cardiovascular Intervention and Therapeutics2022-09-024 citations

Two-year results after coronary stenting of small vessels in Japanese population using 2.25-mm diameter sirolimus-eluting stent with bioresorbable polymer: primary and long-term outcomes of CENTURY JSV study.

2018-01-1810 citations